1. Crizotinib: risk of vision disorders in paediatric patients

   News item 26 November 2022 Pages: 1 - 1

2. FDA warns companies that claim dietary supplements treat CVD

   News item 26 November 2022 Pages: 2 - 2

3. Precautions for use of pemafibrate revised in Japan

   News item 26 November 2022 Pages: 3 - 3

4. Revisions of precautions in Japan in November 2022

   News item 26 November 2022 Pages: 4 - 4

5. BCC and SCC ADRs due to immunosuppressants or hydrochlorothiazide

   Clinical study 26 November 2022 Pages: 5 - 5

6. COVID-19 vaccine-associated Guillain-Barre syndrome

   Clinical study 26 November 2022 Pages: 6 - 6

7. Dedicated system for COVID-19 vaccine safety surveillance at Lareb

   Clinical study 26 November 2022 Pages: 7 - 7

8. Direct-acting antiviral-related gastrointestinal adverse drug reactions

   Clinical study 26 November 2022 Pages: 8 - 8

9. Prevalence of QT-prolonging drugs in elderly patients with dementia

   Clinical study 26 November 2022 Pages: 9 - 9

10. Severe AEs after COVID-19 vaccination following COVID-19 infection

    Clinical study 26 November 2022 Pages: 10 - 10

11. Signals for fetal and neonatal ADRs after in-utero biologics exposure

    Clinical study 26 November 2022 Pages: 11 - 11

12. Update on safety of synthetic and biological DMARDs

    Clinical study 26 November 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 26 November 2022 Pages: 13 - 13

14. β-adrenergic-receptor-antagonists/ivabradine

    Case report 26 November 2022 Pages: 14 - 14

15. Aciclovir/dexamethasone/phenytoin

    Case report 26 November 2022 Pages: 15 - 15

16. Aciclovir/methylprednisolone

    Case report 26 November 2022 Pages: 16 - 16

17. Adalimumab/etanercept

    Case report 26 November 2022 Pages: 17 - 17

18. Adalimumab/infliximab

    Case report 26 November 2022 Pages: 18 - 18

19. Afatinib

    Case report 26 November 2022 Pages: 19 - 19

20. Amiodarone

    Case report 26 November 2022 Pages: 20 - 20

21. Amiodarone

    Case report 26 November 2022 Pages: 21 - 21

22. Amiodarone/colchicine/hydroxychloroquine

    Case report 26 November 2022 Pages: 22 - 22

23. Amiodarone/lidocaine

    Case report 26 November 2022 Pages: 23 - 23

24. Amiodarone/metoprolol/ticagrelor

    Case report 26 November 2022 Pages: 24 - 24

25. Amitriptyline overdose

    Case report 26 November 2022 Pages: 25 - 25

26. Amitriptyline/trazodone

    Case report 26 November 2022 Pages: 26 - 26

27. Amlodipine/bevacizumab

    Case report 26 November 2022 Pages: 27 - 27

28. Amlodipine/regorafenib

    Case report 26 November 2022 Pages: 28 - 28

29. Amoxicillin/clavulanic-acid/ceftriaxone

    Case report 26 November 2022 Pages: 29 - 29

30. Amoxicillin/clavulanic-acid/ciprofloxacin

    Case report 26 November 2022 Pages: 30 - 30

31. Amphotericin B

    Case report 26 November 2022 Pages: 31 - 31

32. Amphotericin B liposomal/deferoxamine

    Case report 26 November 2022 Pages: 32 - 32

33. Amphotericin-b

    Case report 26 November 2022 Pages: 33 - 33

34. Amphotericin-B

    Case report 26 November 2022 Pages: 34 - 34

35. Amphotericin-B/posaconazole

    Case report 26 November 2022 Pages: 35 - 35

36. Ampicillin/sulbactam

    Case report 26 November 2022 Pages: 36 - 36

37. Antibacterials/antihypertensives/norepinephrine

    Case report 26 November 2022 Pages: 37 - 37

38. Antibacterials/vasopressors

    Case report 26 November 2022 Pages: 38 - 38

39. Anticoagulants/antihaemorrhagics

    Case report 26 November 2022 Pages: 39 - 39

40. Anticoagulants/antiplatelets

    Case report 26 November 2022 Pages: 40 - 40

41. Antiemetics/propofol

    Case report 26 November 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 26 November 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 26 November 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 26 November 2022 Pages: 44 - 44

45. Antineoplastics

    Case report 26 November 2022 Pages: 45 - 45

46. Antineoplastics

    Case report 26 November 2022 Pages: 46 - 46

47. Antineoplastics

    Case report 26 November 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 26 November 2022 Pages: 48 - 48

49. Antineoplastics

    Case report 26 November 2022 Pages: 49 - 49

50. Antineoplastics

    Case report 26 November 2022 Pages: 50 - 50